Please login to the form below
real-world study
This page shows the latest real-world study news and features for those working in and with pharma, biotech and healthcare.
Janssen’s Imbruvica shows promise in chronic lymphocytic leukaemia study
The Janssen Pharmaceutical Companies of Johnson &Johnson (Janssen) have shared results from a real-world study evaluating the use of Imbruvica (ibrutinib) in patients with chronic lymphocytic leukaemia (CLL). ... The real-world data demonstrated that
Latest news
-
FDA approves first drug to prevent graft-versus-host disease
The approval is based on data from two trials. In the phase 2 GVHD-1 study, while patients who received Orencia saw a 97% overall survival rate compared to 84% for ... The second trial, a clinical study known as GVHD-2, used real-world data collected by
-
UK expands COVID-19 vaccine plans as winter approaches
The change of policy comes after results from the first real-world study on the effectiveness of the booster jabs were published by the UK Health Security Agency (UKHSA). ... The study showed that two weeks after receiving a booster dose protection
-
US COVID-19 booster programme expanded
booster. In the largest real-world evidence study into a COVID-19 vaccine to date, the J&J vaccine demonstrated 'stable vaccine effectiveness' of 79% against infection and 81% against hospitalisation. ... The company points out that the real-world data
-
New data from Moderna supports COVID boosters
The company also released new data from a real-world study following more than 350, 000 recipients of the vaccine that showed high levels of immunity to the delta variant. ... It is promising to see clinical and real-world evidence adding to the growing
-
Protection against COVID-19 reduces over time in fully vaccinated, according to new real-world study
The Zoe COVID-19 Study shows protection could fall by up to 14%. ... Data from a new real-world study has found that protection against COVID-19 is ‘waning’ in double-vaccinated individuals.
More from news
Approximately 3 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
Putting the ovation into innovation: trends from ESMO
The real value of real-world evidence in advanced breast cancer. Real-world evidence (RWE) is playing an ever- increasing role in treatment decision-making, in all forms of cancer. ... The first approved CDK4/6 inhibitor, palbociclib (IBRANCE) showcased
-
AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma
designs using real-world data and AI for various cancers. ... for peer recommendation or concrete real-world evidence prior to adopting the AI tools.
-
Innovation through collaboration – the importance of partnerships
At our Wrexham site, we manufacture medicines that are exported all over the world to help alleviate symptoms of spasticity in patients. ... The pilot study will evaluate the real-world use of GripAble, during routine clinical practice in patients
-
Recruiting patients for real-world studies – the power of a digital campaign
Yet, for all their useful applications, it is difficult to enrol patients in real-world studies via traditional means. ... The study met its enrolment target in under six months. As real-world studies gain importance, study sponsors must turn to the most
-
The long and winding road to asthma breakthroughs
The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world evidence study – presented at the recent European Respiratory Society’s International ... We also developed specific
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study. ... Our Hyperlipidaemia infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study, which uses
-
Webcast: Demand Assessment
Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market. ... In this webcast, Richard Goosey, Head of Analytics, and quantitative expert, Will Tolley find out how a study design which
-
Training for PI's and study staff has to change now
Well, it could involve tailoring training to a specific study and going beyond the basic GCP elements that most people already know anyway. ... In the real world, training could be a study that has an inherently small potential patient population due to
-
Carenity - ELSE CARE SAS
ELSE CARE SAS is digital CRO that could generate patients' insights through its direct-access to patient platform Carenity, allowing Real World Evidence generation for non interventional study at each step
-
Webinar: Demand assessment - Reflecting real world choices
How study design which reflects doctors’ real world choices can optimise results. ... study design which reflects doctors’ real world choices can optimise results.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
PMHub
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
